Target intelligence / Profile preview

Glutamate dehydrogenase 1 pseudogene 8 (GLUD1P8)

Target
GLUD1P8
Molecular classification
Other (Pseudogene)
01

Overview

Glutamate dehydrogenase 1 pseudogene 8 (GLUD1P8) is a human genomic sequence annotated as a pseudogene related to the functional GLUD1 gene, which encodes glutamate dehydrogenase 1. Unlike the active gene, GLUD1P8 does not produce a functional protein, and there is no evidence for its biological activity, disease involvement, or drug interaction. It is grouped with genomic pseudogenes and is not considered a valid therapeutic target[2].

Other names
GLUDP8bA144G6.5

Beyond the preview

Go deeper on Glutamate dehydrogenase 1 pseudogene 8 (GLUD1P8).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glutamate dehydrogenase 1 pseudogene 8 (GLUD1P8).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call